Japanese | English

Œ¤‹†ŽÒƒf[ƒ^ƒx[ƒX
–¼‘OF ‘º“c ‹M”V(Takayuki Murata)
Œ¤‹†•ª–ì‚ÌKeywordF EBƒEƒCƒ‹ƒX
ŠÌ‰ŠƒEƒCƒ‹ƒX
ƒEƒCƒ‹ƒX”­‚ª‚ñ
RƒEƒCƒ‹ƒX–ò
ƒ^ƒ“ƒpƒNŽ¿‚Ì–|–óŒãCü
ƒVƒOƒiƒ‹“`’B
ƒGƒsƒWƒFƒlƒeƒBƒbƒNƒX‚Æ“]ŽÊ

Š‘®‹@ŠÖ/‘gD (#1)
Š‘®‹@ŠÖ–¼-1F “¡“c•ÛŒ’‰q¶‘åŠw
Š‘®•”–¼(1) 1F ˆãŠw•”@ˆãŠw‰È
–ðEEE–¼-1F ‹³Žö
—X•Ö”ԍ†-1F 470-1192
ZŠ-1F ˆ¤’mŒ§–L–¾ŽsŒBŠ|’¬“cŠyƒ–ŒE1-98
“d˜b”ԍ†-1F 0562-93-2634
FAX”ԍ†-1F 0562-93-4593

‹³ˆçî•ñ (#1)
‰È–Ú–¼-1F ƒEƒCƒ‹ƒXEŠñ¶’ŽŠw

Š‘®Šw‰ï^Œ¤‹†‰ï (#1)
Š‘®Šw‰ï–¼-1F “ú–{ƒEƒCƒ‹ƒXŠw‰ï
Š‘®Šw‰ï–ðˆõEˆÏˆõ‰ï“™-1F •]‹cˆõ
Š‘®Šw‰ï^Œ¤‹†‰ï (#2)
Š‘®Šw‰ï–¼-2F “ú–{ŠàŠw‰ï
Š‘®Šw‰ï–ðˆõEˆÏˆõ‰ï“™-2F ‰ïˆõ

Œ¤‹†—ð^ŽÀÑ [2017”N] (#24)
˜_•¶-24F Yoshida M, Murata T*, Ashio K, Narita Y, Watanabe T, Masud HMAA, Sato Y, Goshima F, Kimura H. Characterization of a Suppressive Cis-acting Element in the Epstein-Barr Virus LMP1 Promoter. Front Microbiol. 2017 Nov 22;8:2302.

Masud HMAA, Watanabe T, Yoshida M, Sato Y, Goshima F, Kimura H, Murata T*. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production. J Virol. 2017 Nov 14;91(23). pii: e00975-17.

Yoshida M, Watanabe T, Narita Y, Sato Y, Goshima F, Kimura H, Murata T*. The
Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293
cells and Transformation. Sci Rep. 2017 Jul 20;7(1):6044.

Watanabe T, Sakaida K, Yoshida M, Masud HMAA, Sato Y, Goshima F, Kimura H, Murata T*. The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for its Proper Localization and Efficient Virus Production. Front Microbiol. 2017 Jan 31;8:125.
Œ¤‹†—ð^ŽÀÑ [2018”N] (#25)
˜_•¶-25F Konishi N, Narita Y, Hijioka F, Masud HMAA, Sato Y, Kimura H, Murata T*. BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection. mSphere. 2018 Apr 25;3(2). pii: e00138-18.

Fri Jun 1 13:37:07 JST 2018

Login page
All Page